Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imaizumi, Y.
Right arrow Articles by Matsuyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imaizumi, Y.
Right arrow Articles by Matsuyama, T.
Clinical Cancer Research Vol. 9, 181-187, January 2003
© 2003 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Expression of the c-Met Proto-Oncogene and Its Possible Involvement in Liver Invasion in Adult T-cell Leukemia1

Yoshitaka Imaizumi, Hiroyuki Murota, Shigeru Kanda, Yoshitaka Hishikawa, Takehiko Koji, Takashi Taguchi, Yuetsu Tanaka, Yasuaki Yamada, Shuichi Ikeda, Tomoko Kohno, Kazuo Yamamoto, Naoki Mori, Masao Tomonaga and Toshifumi Matsuyama2

Divisions of Cytokine Signaling [Y. I., H. M., To. K., K. Y., T. M.] and Endothelial Cell Biology [S. K.], Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Medical Sciences and Departments of Laboratory Medicine [Y. Y.], Hematology, Atomic Disease Institute [Y. I., M. T.], and Histology and Cell Biology [Y. H., Ta. K.] and Second Department of Pathology [T. T.], Nagasaki University School of Medicine, Nagasaki 852-8523; Departments of Infectious Disease and Immunology, Okinawa-Asia Research Center of Medical Science [Y. T.], and Virology [N. M.], Faculty of Medicine, University of the Ryukyus, Okinawa 903-0215; and Department of Medicine, City of Sasebo General Hospital, Sasebo 857-8511 [S. I.], Japan

c-Met is a tyrosine kinase receptor for hepatocyte growth factor and suggested to be involved in oncogenesis ormetastatic phenotypes in many malignancies. Adult T-cell leukemia (ATL) is a neoplasia characterized by massive invasion of the leukemic cells into various organs. Recently, we have reported frequent hepatic involvement and the relationship between liver invasion and the poor prognosis in ATL. In the present study, we investigated the expression of c-Met in ATL cells and its relation to liver dysfunction. In three of four human T-cell lymphotrophic virus-I-positive T-cell lines, c-Met was expressed both at mRNA and protein levels, whereas it was not expressed in human T-cell lymphoma virus-I-negative T-cell lines. The expressed c-Met should be functional, because hepatocyte growth factor could induce the autophosphorylation of c-Met. Although the viral-transactivating protein Tax has been shown to be involved in the deregulated expression of cellular genes, Tax mRNA was not detected in c-Met mRNA-expressed cell lines. From freshly isolated peripheral blood mononuclear cells, the expression of c-Met mRNA was detected in 10 of 16 ATL patients but not from healthy individuals. Finally, serum transaminase levels were significantly increased in c-Met-positive ATL cases, and all of the infiltrated c-Met-positive cells into liver were shown to be multilobularly nucleated phenotype. Taken together, these data suggest for the first time that c-Met is involved in the liver invasive phenotype of ATL.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Okunishi, M. Dohi, K. Fujio, K. Nakagome, Y. Tabata, T. Okasora, M. Seki, M. Shibuya, M. Imamura, H. Harada, et al.
Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice
J. Immunol., October 15, 2007; 179(8): 5504 - 5513.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Accordi, S. Pillozzi, M. C. Dell'Orto, G. Cazzaniga, A. Arcangeli, G. t. Kronnie, and G. Basso
Hepatocyte Growth Factor Receptor c-MET Is Associated with FAS and When Activated Enhances Drug-induced Apoptosis in Pediatric B Acute Lymphoblastic Leukemia with TEL-AML1 Translocation
J. Biol. Chem., October 5, 2007; 282(40): 29384 - 29393.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Okunishi, M. Dohi, K. Nakagome, R. Tanaka, S. Mizuno, K. Matsumoto, J.-i. Miyazaki, T. Nakamura, and K. Yamamoto
A Novel Role of Hepatocyte Growth Factor as an Immune Regulator through Suppressing Dendritic Cell Function
J. Immunol., October 1, 2005; 175(7): 4745 - 4753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.